HOXB4 and colorectal carcinoma: To identify whether the up-regulation of HOXB4 was critical to promoting the progression of CRC and was employed as an important biomarker for clinical treatment, we performed the GEPIA to evaluate HOXB4 expression in different clinical stages of COAD.